What are the sensitivity and specificity of serial symphysis‑fundal height (SFH) screening for detecting small‑for‑gestational‑age fetuses at each gestational age (e.g., 24, 28, 32, 36, and 38‑40 weeks)?

Sensitivity and Specificity of Serial Symphysis-Fundal Height Screening by Gestational Age

Serial symphysis-fundal height (SFH) measurement has poor to moderate sensitivity (19–51%) but high specificity (80–98%) for detecting small-for-gestational-age (SGA) fetuses, with performance improving significantly as pregnancy advances toward term. 1

Overall Performance Characteristics

Sensitivity by Population Risk Level

The diagnostic accuracy of SFH varies substantially based on the underlying risk profile of the population being screened:

• Low-risk populations: Sensitivity 19–21% for SGA detection; 28% for severely SGA (<2.3rd centile) 1
• Mixed-risk populations: Sensitivity increases to 32–44% 1
• High-risk populations: Sensitivity 37% for SGA; 53% for severe SGA 1
• Large cohort data: Overall sensitivity of 47% in a Swedish study of 42,018 women 1, 2

Specificity Across All Populations

• Specificity remains consistently high at 80–98% across all risk categories, making SFH useful for ruling in rather than ruling out SGA 1

Performance by Gestational Age

Early Third Trimester (24–28 weeks)

• SFH accounts for only 3% of individual birthweight variance at 24 weeks 2
• Routine measurements between 24+0 and 26+7 weeks generate excessive false-positive referrals due to unstable centile relationships at earlier gestations 1, 3, 4
• The first routine SFH measurement should be performed between 26+0 and 28+6 weeks, with completion by 28+6 weeks to avoid high referral rates while maintaining detection capability 1, 3

Mid Third Trimester (28–34 weeks)

• SFH predictive value increases gradually, accounting for approximately 10–15% of birthweight variance by 32 weeks 2
• Serial measurements with four or more readings after 26 weeks achieve sensitivity of 65% for SGA detection and 91% for severe SGA (<5th centile), with specificity of 80–81% 5

Late Third Trimester (34–40 weeks)

• SFH performs best near term, with predictive value reaching its peak 1, 2
• At 40 weeks, SFH accounts for 20% of individual birthweight variance 2
• Only the most recent SFH measurement has predictive value; previous measurements or static/falling patterns do not increase SGA likelihood beyond the current reading 2

Critical Technical Considerations

Measurement Protocol

• Measure from the uterine fundus to the symphysis pubis with the tape concealed from the examiner to minimize observer bias 1, 3, 4
• Serial measurements improve accuracy compared to single assessments, reducing intra- and inter-observer variation 1, 4
• Measurements should be performed no more frequently than every 2 weeks 1

Conditions That Invalidate SFH Screening

SFH measurement is unreliable and should not be used in the following circumstances:

• Maternal BMI ≥35 kg/m² at booking 1, 3, 4
• Large uterine fibroids (based on clinical judgment) 1, 3, 4
• Abnormal fetal lie (transverse or oblique presentation) 1, 3, 4
• Polyhydramnios of any etiology 1, 3, 4
• Fetal head engagement in the pelvis 1, 3, 4

All women should be assessed at booking for these conditions to determine whether SFH surveillance is appropriate or whether direct ultrasound monitoring should be employed instead. 1, 3, 4

Referral Criteria and Clinical Action

Indications for Ultrasound Assessment

• Single SFH measurement plotting below the 10th centile warrants ultrasound evaluation 1, 3, 4
• Two measurements taken >2 weeks apart showing no increase in SFH requires ultrasound assessment 1, 3, 4
• Urgency of ultrasound referral should be modulated by additional clinical findings such as reduced fetal movements or abnormal maternal blood pressure 1, 3, 4

Comparison with Alternative Screening Methods

Abdominal Palpation

• Abdominal palpation has limited accuracy (sensitivity 19–21%, specificity 98%) and should not be routinely used for SGA detection 1
• SFH measurement is superior to palpation alone, though both methods have significant limitations 1

Ultrasound Estimated Fetal Weight

• Ultrasound is more sensitive than SFH for detecting SGA, but even when performed close to birth, sensitivity remains suboptimal 1
• Combining longitudinal SFH with triggered ultrasound (when SFH criteria are met) achieves a positive predictive value of 74% and negative predictive value of 92% for SGA 6

Clinical Context and Limitations

Despite poor sensitivity, SFH remains a reasonable first-level screening tool for low-risk pregnancies because it is easily performed, requires minimal resources, and has essentially no adverse effects related to the test itself 1, 3. In resource-limited settings where universal ultrasound surveillance is not feasible, SFH enables selective referral for ultrasound, optimizing the use of limited imaging resources 3.

The key pitfall is over-reliance on SFH in populations where it is known to perform poorly (obese women, multiple gestations, polyhydramnios). In these cases, direct ultrasound surveillance should be the primary modality from the outset 1, 3, 4.